Photodynamic therapy for age-related macular degeneration.
作者信息
Beck Roy W
出版信息
Am J Ophthalmol. 2004 Sep;138(3):513; author reply 513-4. doi: 10.1016/j.ajo.2004.05.022.
PMID:15364257
Abstract
摘要
相似文献
1
Photodynamic therapy for age-related macular degeneration.
Am J Ophthalmol. 2004 Sep;138(3):513; author reply 513-4. doi: 10.1016/j.ajo.2004.05.022.
2
Photodynamic therapy for age-related macular degeneration: a candid appraisal.
Am J Ophthalmol. 2004 Mar;137(3):483-5. doi: 10.1016/j.ajo.2003.11.023.
3
Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration.
Arch Ophthalmol. 1999 Oct;117(10):1400-2. doi: 10.1001/archopht.117.10.1400.
4
Influence of lesion size on treatment benefit with photodynamic therapy.
Clin Exp Ophthalmol. 2004 Aug;32(4):452-3. doi: 10.1111/j.1442-9071.2004.00860.x.
5
Comment on 'Photodynamic therapy in practice'.
Clin Exp Ophthalmol. 2004 Feb;32(1):119-20. doi: 10.1046/j.1442-9071.2004.00776.x.
6
Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
Ophthalmic Surg Lasers Imaging. 2005 May-Jun;36(3):258-60.
7
Are the submacular surgery trials still relevant in an era of photodynamic therapy?
Ophthalmology. 2001 Mar;108(3):435-6. doi: 10.1016/s0161-6420(00)00666-7.
8
Treatment of choroidal neovascularization in AMD.
Ophthalmology. 2006 Dec;113(12):2372; author reply 2372-3. doi: 10.1016/j.ophtha.2006.07.005.
9
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
Arch Ophthalmol. 2005 Sep;123(9):1283-5. doi: 10.1001/archopht.123.9.1283.
10
[Results of photodynamic treatment of choroidal neovascular membrane in age-related macular degeneration].
Cas Lek Cesk. 2006;145(10):800, 802-3.
Zotero 插件